Growth Metrics

Palisade Bio (PALI) Long-Term Debt Repayments (2012 - 2017)

Palisade Bio (PALI) reported Long-Term Debt Repayments of $2.5 million for Q2 2017, up 125.24% year-over-year from $1.1 million in Q2 2016, and up 108.02% on a QoQ basis from $1.2 million in Q1 2017.

Palisade Bio (PALI) has 5 years of Long-Term Debt Repayments data on file, last reported at $2.5 million in Q2 2017.

  • Quarterly Long-Term Debt Repayments rose 125.24% year-over-year to $2.5 million in Q2 2017, while the trailing twelve-month figure through Dec 2017 was $3.8 million (down 17.59% YoY) and the FY2017 annual result came in at $3.8 million, down 17.59% from the prior year.
  • Long-Term Debt Repayments climbed to $2.5 million in Q2 2017 per PALI's latest filing, from $1.2 million in the prior quarter.
  • Across five years, Long-Term Debt Repayments topped out at $2.5 million in Q2 2017 and bottomed at $12096.0 in Q4 2014.
  • The 4-year median for Long-Term Debt Repayments is $1.1 million (2016), against an average of $1.0 million.
  • The widest annual swing landed in 2015, when Long-Term Debt Repayments soared 9441.58%; it then increased 2.9% in 2016.
  • Tracing PALI's Long-Term Debt Repayments over 4 years: stood at $12096.0 in 2014, then soared by 9441.58% to $1.2 million in 2015, then rose by 2.9% to $1.2 million in 2016, then surged by 114.13% to $2.5 million in 2017.
  • Per Business Quant, the three latest PALI Long-Term Debt Repayments figures stand at $2.5 million (Q2 2017), $1.2 million (Q1 2017), and $1.2 million (Q4 2016).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Long-Term Debt Repayments (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn - -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn - -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn -
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn - -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn - -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn -
7 Evaxion A 62.56 Bn 62.54 Bn - -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn -
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn -
10 Palisade Bio 439.25 Mn 309.68 Mn - -

Historic Data

Download Data 🔒
DateValue
Jun 30, 2017 2.54 Mn
Jun 30, 2017 2.54 Mn
Mar 31, 2017 1.22 Mn
Mar 31, 2017 1.22 Mn
Dec 31, 2016 1.19 Mn
Dec 31, 2016 1.19 Mn
Sep 30, 2016 1.16 Mn
Sep 30, 2016 1.16 Mn
Jun 30, 2016 1.13 Mn
Jun 30, 2016 1.13 Mn
Mar 31, 2016 1.10 Mn
Mar 31, 2016 1.10 Mn
Dec 31, 2015 1.15 Mn
Dec 31, 2015 1.15 Mn
Dec 31, 2014 12,096.00
Dec 31, 2014 12,096.00
Sep 30, 2014 492,230.00
Sep 30, 2014 492,230.00
Jun 30, 2014 720,305.00
Jun 30, 2014 720,305.00
Mar 31, 2014 704,818.00
Mar 31, 2014 704,818.00
Dec 31, 2012 -16,272.00
Dec 31, 2012 -16,272.00
Sep 30, 2012 16,272.00
Sep 30, 2012 16,272.00